Peptides for Perimenopause: What the Research Actually Says
A grounded look at peptides discussed for perimenopause — GH-axis peptides, BPC-157, kisspeptin, collagen — and where the evidence is strong versus preliminary.
By Anthivera Editorial · Updated · 1 min read
Awaiting medical reviewDraft
Status: Stub. Outline is in place per
/docs/CONTENT-PLAN.md(Article 2).
What changes biologically in perimenopause#
Section content TBD. GH decline, estrogen fluctuation, body composition, joint pain, sleep.
The honest framing#
Section content TBD. Peptides are discussed as potential adjuncts, not replacements for proven care (HRT, lifestyle).
GH-axis peptides — sermorelin, ipamorelin#
Section content TBD. What the limited clinical data shows for body composition and sleep.
BPC-157 for joint and tissue complaints#
Section content TBD. Strong preclinical evidence; weak human evidence — stated plainly.
Kisspeptin#
Section content TBD. Mechanistically interesting; lacks combination-trial data.
Collagen peptides#
Section content TBD. The best-studied, lowest-risk option in this list.
What peptides do not do that HRT does#
Section content TBD. Clear boundaries.
Questions to bring to a Menopause Society Certified Practitioner#
Section content TBD. Link to Article 7 (how to find a peptide doctor).